Unnamed: 0 int64 1 868 | section stringclasses 51
values | subsection stringclasses 4
values | label stringclasses 9
values | text stringlengths 1 98.9k |
|---|---|---|---|---|
298 | Case 21 | Important Radiologic | HR(−) HER2(−) Breast Cancer | Important Radiologic Findings. 144 145 146. 147. . HR(−) HER2(−) Breast Cancer. 648. . . . . . E. S. Lee et al.. 649. . After Neoadjuvant. Chemotherapy. 148 149 150. 151. 21.3. |
304 | Case 21 | Patient History | HR(−) HER2(−) Breast Cancer | Patient History and Progress. Female/50 years old, pre-menopause.. Screen detected mass lesion on left breast 1. o’clock direction.. No family history.. No comorbidities.. BRCA 1 and 2 mutation: Not detected, STK11. VUS (variant of uncertain).. 21.2. |
291 | Case 21 | Courses of Treatment | Local Recurrence | 21.1. . Courses of Treatment. Right breast DCIS→ → Operation → Right. breast recurrence (DCIS).. Y. Kim et al.. 775. Primary Treatment. 146. Operation. . 147. 148. Pathology Report. Ductal Carcinoma In Situ. . 1. Size of tumor: 5.5 cm (pTis).. . 2. Nuclear grade: low.. . 3. Necrosis: present.. . 4. Architectural ... |
305 | Case 21 | Patient History | Local Recurrence | Patient History and Progress. Female/55 years old, peri-menopause.. Screen detected calcification on upper portion. of right breast.. Outside result of biopsy: suggestive ductal. carcinoma in situ.. No family history.. S/p hysterectomy.. 21.2. |
292 | Case 21 | Courses of Treatment | Metastatic Breast Cancer | Left breast cancer → Operation → Adjuvant. therapy → Neck node recurrence → Lymph. nodes, bone metastasis → Skull, brain. metastasis.. Primary Treatment. Operation. Apr. 2002 Left breast conserving surgery, senti. nel lymph node biopsy.. Y. Kwon et al.. 895. Pathology: Microinvasive infiltrating duct car. cinoma, sta... |
306 | Case 22 | Courses of Treatment | Benign and Proliferative | 22.1. . Courses of Treatment. →2021-07-07 excision, Rt.. Diagnosis. • Breast, right, excision:. –. – Atypical. ductal. hyperplasia. with. microcalcification.. . C. W. Lee et al.. 45. . . . 23. |
314 | Case 22 | Important Radiologic | Benign and Proliferative | Important Radiologic. Findings. 42. 22.3. |
320 | Case 22 | Patient History | Benign and Proliferative | Patient History and Progress. Female/50 years old, peri-menopause.. Screen detected microcalcification on upper. outer portion of right breast.. No family history.. Hypertension (taking medication), carotid. atherosclerosis.. 22.2. |
307 | Case 22 | Courses of Treatment | Carcinoma In Situ | 22.1. . Courses of Treatment:. Operation. Operation. 103. 104. Pathology Report. Ductal carcinoma in situ, pathological TN cat. egory (AJCC 2017): pTis(Paget)N0(sn). . 1. Size of tumor: 0.5 cm (pTis(Paget)).. . 2. Nuclear grade: high.. . 3. Necrosis: absent.. . 4. Architectural pattern: micropapillary.. . 5. Nip... |
315 | Case 22 | Important Radiologic | Carcinoma In Situ | Important Radiologic. Findings. 100 101. 102. 22.3. |
321 | Case 22 | Patient History | Carcinoma In Situ | Patient History and Progress. Female/57 years old, post-menopause.. Visible detected redness on Left nipple.. Outside result of biopsy: Paget’s disease.. Family history of breast cancer, sister at her. 45 years old.. No comorbidities.. BRCA 1 and 2 mutation: Not detected.. 22.2. |
308 | Case 22 | Courses of Treatment | HR(+) HER2(+) Breast Cancer | 22.1. . Courses of Treatment. Neoadjuvant chemotherapy (#6 cycles of. docetaxel and carboplatin and trastuzumab. and pertuzumab) + Operation + Trastuzumab. + Letrozole 2.5 mg/day.. 125. Pathology Report. Invasive Ductal Carcinoma. 1. Post-chemotherapy status.. 2. Size of tumor: 0.5 cm (ypT1a).. S. Park et al.. 369. ... |
316 | Case 22 | Important Radiologic | HR(+) HER2(+) Breast Cancer | Important Radiologic. Findings. 118 119 120 121 122 123. 124. 22.3. |
322 | Case 22 | Patient History | HR(+) HER2(+) Breast Cancer | Patient History and Progress. Female/54 years old, post-menopause.. Self-detected nipple retraction on left breast.. No family history.. Hepatitis B carrier.. 22.2. |
309 | Case 22 | Courses of Treatment | HR(+) HER2(-) Breast Cancer | . Courses of Treatment. Neoadjuvant chemotherapy (#4 cycles of. doxorubicin & cyclophosphamide followed by. #4 cycles of docetaxel) + Operation + Post-. operative radiation therapy + Letrozole. 2.5 mg/day.. Operation. tumor.. 6. Surgical margins:. . (a) deep margin: positive for invasive carci. noma (slide... |
317 | Case 22 | Important Radiologic | HR(+) HER2(-) Breast Cancer | Important Radiologic. Findings. See Figs. 119, 120, 121, 122, 123 and 124.. 22.3. |
323 | Case 22 | Patient History | HR(+) HER2(-) Breast Cancer | Patient History and Progress. Female/61 years old, post-menopause.. Screen detected mass lesion on entire left. breast.. No family history.. Diabetes mellitus, Spinal stenosis.. 22.2. |
310 | Case 22 | Courses of Treatment | HR(−) HER2(+) Breast Cancer | 22.1. . Courses of Treatment. Operation + Adjuvant chemotherapy (#4 cycles. of doxorubicin and cyclophosphamide) + Post-. operative radiation therapy + Trastuzumab.. Operation. 161. . a. b. . HR(−) HER2(+) Breast Cancer. 518. Pathology Report. Invasive Ductal Carcinoma with apocrine dif. ferentiation and medullary... |
318 | Case 22 | Important Radiologic | HR(−) HER2(+) Breast Cancer | Important Radiologic Findings. 157 158 159. 160. . . . Y. Kwon et al.. 517. 22.3. |
324 | Case 22 | Patient History | HR(−) HER2(+) Breast Cancer | Patient History and Progress. Female/53 years old, peri-menopause.. Self-detected palpable mass lesion on right. breast 4 o’clock direction.. No family history.. S/P hemorrhoids operation.. 22.2. |
311 | Case 22 | Courses of Treatment | HR(−) HER2(−) Breast Cancer | 22.1. . Courses of Treatment. Neoadjuvant chemotherapy (#4 cycles of. doxorubicin and cyclophosphamide + #4. cycles of docetaxel) + Operation + Post-. operative radiation therapy + Adjuvant. capecitabine.. Operation. 161. Pathology Report. Invasive Ductal Carcinoma. 1. Post-chemotherapy status.. 2. Size of ... |
319 | Case 22 | Important Radiologic | HR(−) HER2(−) Breast Cancer | Important Radiologic. Findings. 153 154 155. 156. HR(−) HER2(−) Breast Cancer. 652. . . . . . E. S. Lee et al.. 653. . After Neoadjuvant. Chemotherapy. 157 158 159. 160. 22.3. |
325 | Case 22 | Patient History | HR(−) HER2(−) Breast Cancer | Patient History and Progress. Female/57 years old, post-menopause.. Self-detected palpable mass lesion on right. breast.. Family history of breast cancer, uncle. (paternal).. s/p retinal detachments operation.. BRCA 1 and 2 mutation: Not detected, PALB2. PV, STK11 VUS (variant of uncertain).. 22.2. |
312 | Case 22 | Courses of Treatment | Local Recurrence | 22.1. . Courses of Treatment. Left breast mucinous carcinoma→ Adjuvant. therapy → Right breast recurrence (mucinous. carcinoma).. Primary Treatment. 152. Operation. Apr. 2007 Left breast mass excision (outside).. Pathology Report. Mucinous Carcinoma. . 1. Size of tumor: 2.0 cm.. . 2. Margin involved.. Result. Intens... |
326 | Case 22 | Patient History | Local Recurrence | Patient History and Progress. Female/80 years old, post-menopause.. Screen detected mass lesion on upper outer. portion of Left breast.. Outside. result. of. biopsy:. Mucinous. carcinoma.. No family history.. Dementia.. BRCA 1 and 2 mutation: No examination.. 22.2. |
313 | Case 22 | Courses of Treatment | Metastatic Breast Cancer | Courses of Treatment. Left breast cancer → Operation → Adjuvant. therapy → Right axillary lymph node recur. rence → Right breast recurrence → Chest wall. → Bone → Pleural effusion metastasis.. Primary Treatment. mide #3 → Doxorubicin + Docetaxel #3).. Operation. Mar. 2008 Left total mastectomy, axillary lymph. node di... |
327 | Case 22 | Patient History | Metastatic Breast Cancer | |
328 | Case 23 | Courses of Treatment | Benign and Proliferative | 23.1. . Courses of Treatment. →2021-07-13 Excision, Lt.. Benign and Proliferative Case Series. 46. Pathology Report. Diagnosis. • Breast, left, excision:. –. – Atypical ductal hyperplasia involving intra. ductal papilloma with microcalcification.. 24. |
336 | Case 23 | Important Radiologic | Benign and Proliferative | Important Radiologic. Findings. 43 44. 45. 23.3. |
342 | Case 23 | Patient History | Benign and Proliferative | Patient History and Progress. Female/47 years old, pre-menopause.. Screen detected mass lesion on left breast 1. o’clock direction.. Outside result of biopsy: atypical papilloma.. No family history.. No comorbidities.. 23.2. |
329 | Case 23 | Courses of Treatment | Carcinoma In Situ | 23.1. . Courses of Treatment:. Operation. Operation. 107. 108. Pathology Report. Lobular carcinoma in situ, pathological TN. category (AJCC 2017): pTis. . 1. Size of tumor: 0.5 cm (pTis).. . 2. Nuclear grade: low.. . 3. Necrosis: absent.. . 4. Architectural pattern: solid.. . 5. Skin: no involvement of tumor.. . ... |
337 | Case 23 | Important Radiologic | Carcinoma In Situ | Important Radiologic. Findings. 105. 106. 23.3. |
343 | Case 23 | Patient History | Carcinoma In Situ | Patient History and Progress. Female/44 years old, pre-menopause.. Screen detected microcalcification on upper. outer portion of right breast.. No family history.. No comorbidities.. 23.2. |
330 | Case 23 | Courses of Treatment | HR(+) HER2(+) Breast Cancer | 23.1. . Courses of Treatment. Neoadjuvant chemotherapy (#6 cycles of. docetaxel and carboplatin and trastuzumab. and pertuzumab) + Operation + Post-. HR(+) HER2(+) Breast Cancer. 374. . . . operative radiation therapy + Trastuzumab +. Tamoxifen 20 mg/day.. . . 132. 133. Pathology Report. . 1. No residual tumo... |
338 | Case 23 | Important Radiologic | HR(+) HER2(+) Breast Cancer | Important Radiologic. Findings. 126 127 128 129 130. 131. 23.3. |
344 | Case 23 | Patient History | HR(+) HER2(+) Breast Cancer | Patient History and Progress. Female/46 years old, pre-menopause.. Self-detected palpable mass lesion on both. breast.. Family history of breast cancer, sister.. Hypertension, S/P varicose veins operation.. BRCA 1 and 2 mutation: Not detected. (BRCAPRO mutation probability 0.118).. 23.2. |
331 | Case 23 | Courses of Treatment | HR(+) HER2(-) Breast Cancer | 2.5 mg/day.. Operation. Right breast conserving surgery, sentinel lymph. . (d) Histologic grade: 3/3 (tubule formation:. 3/3, nuclear pleomorphism: 3/3, mitotic. count: 2/3, 10/10 HPF). . (e) Intraductal component: present, intratu. moral/extratumoral. (99%). (nuclear. grade: high, necrosis: present, architec. tura... |
339 | Case 23 | Important Radiologic | HR(+) HER2(-) Breast Cancer | Important Radiologic. Findings. See Figs. 126, 127, 128, 129 and 130.. Y. Kim et al. |
345 | Case 23 | Patient History | HR(+) HER2(-) Breast Cancer | sister.. Diabetes mellitus, s/p right thyroidectomy. (thyroid cancer), s/p cholecystectomy, s/p. hysterectomy.. BRCA 1 and 2 mutation: Not detected.. 23.2. |
332 | Case 23 | Courses of Treatment | HR(−) HER2(+) Breast Cancer | 23.1. . Courses of Treatment. Operation + Operation + Adjuvant paclitaxel and. trastuzumab.. Operation. . 166. Pathology Report. Breast, right, nipple-sparing mastectomy:. Microinvasive Ductal Carcinoma. 1. Size of invasive component: <0.1 cm. (pT1mi).. 2. Size of intraductal component: 6.0 cm.. 3. Histologic gra... |
340 | Case 23 | Important Radiologic | HR(−) HER2(+) Breast Cancer | Important Radiologic. Findings. 162 163 164. 165. . Y. Kwon et al.. 519. . . . . 23.3. |
346 | Case 23 | Patient History | HR(−) HER2(+) Breast Cancer | Patient History and Progress. Female/49 years old, pre-menopause.. Self-detected bloody discharge on nipple of. right breast.. No family history.. No comorbidities.. 23.2. |
333 | Case 23 | Courses of Treatment | HR(−) HER2(−) Breast Cancer | 23.1. . Courses of Treatment. Neoadjuvant chemotherapy (#4 cycles of. doxorubicin and cyclophosphamide + #4. cycles of docetaxel) + Operation + Post-. operative radiation therapy.. Operation. 169. E. S. Lee et al.. 657. . . . . HR(−) HER2(−) Breast Cancer. 658. . . . Pathology Report. No residual tumor with fo... |
341 | Case 23 | Important Radiologic | HR(−) HER2(−) Breast Cancer | Important Radiologic Findings. 162 163. 164. After Neoadjuvant. Chemotherapy. 165 166 167. 168. 23.3. |
347 | Case 23 | Patient History | HR(−) HER2(−) Breast Cancer | Patient History and Progress. Female/56 years old, post-menopause.. Self-detected mass lesion on right breast.. Family history of breast cancer, aunt. (maternal).. s/p Right knee fracture operation.. BRCA 1 and 2 mutation: Not detected,. POLD1 VUS (variant of uncertain).. 23.2. |
334 | Case 23 | Courses of Treatment | Local Recurrence | 23.1. . Courses of Treatment. Left breast medullary carcinoma → Operation. → Adjuvant therapy → Left breast recurrence. (IDC)/Right breast intraductal papilloma.. Primary Treatment. Operation. 2003 Left breast conserving surgery, axillary. lymph node dissection (outside).. Pathology Report. Medullary Carcinoma.. Y. Ki... |
348 | Case 23 | Patient History | Local Recurrence | Patient History and Progress. Female/49 years old, pre-menopause.. Palpable mass lesion on left breast 2 o’clock. direction.. Family history of breast cancer, maternal. grandmother.. s/p Left breast conserving surgery (breast can. cer), s/p Bilateral salpingo-oophorectomy.. BRCA 1 mutation carrier.. 23.2. |
335 | Case 23 | Courses of Treatment | Metastatic Breast Cancer | Courses of Treatment. Left breast cancer → Neoadjuvant chemother. apy → Operation → Adjuvant therapy →. Pericardial effusion, Metastatic lymph nodes. → Bone, brain metastasis.. Primary Treatment. Docetaxel #4).. Result. Intensity. Positive. %. Estrogen. receptor. Negative (0/7). 0. 0. Progesterone. receptor. Negative ... |
349 | Case 23 | Patient History | Metastatic Breast Cancer | |
350 | Case 24 | Courses of Treatment | Benign and Proliferative | 24.1. . Courses of Treatment. →2021-07-14 excision, both.. . . C. W. Lee et al.. 47. . . Pathology Report. Diagnosis. • Breast, right, excision:. –. – Intraductal papilloma.. Post-excision status.. Usual ductal hyperplasia.. Apocrine metaplasia.. –. – Sclerosing adenosis with microcalcification.. Diagnosis. • Breast... |
358 | Case 24 | Important Radiologic | Benign and Proliferative | Important Radiologic. Findings. 46 47. 48. 24.3. |
364 | Case 24 | Patient History | Benign and Proliferative | Patient History and Progress. Female/44 years old, pre-menopause.. Screen detected mass lesion in both breasts.. No family history.. s/p total thyroidectomy (thyroid cancer), s/p. right breast excision (intraductal papilloma).. 24.2. |
351 | Case 24 | Courses of Treatment | Carcinoma In Situ | 24.1. . Courses of Treatment:. Operation. Operation. 112. 113. E. S. Lee et al.. . 2. Nuclear grade: low.. . 3. Necrosis: absent.. . 4. Architectural pattern: solid.. . 5. Surgical margins:. . (a) superior margin: 11 mm,. . (b) inferior margin: 3 mm,. . (c) medial margin: 15 mm,. . (d) lateral margin: 15 mm,. ... |
359 | Case 24 | Important Radiologic | Carcinoma In Situ | Important Radiologic. Findings. 109 110 111. 24.3. |
365 | Case 24 | Patient History | Carcinoma In Situ | Patient History and Progress. Female/42 years old, pre-menopause.. Screen detected mass lesion on left breast. 2 o’clock direction.. Outside result of biopsy: Left breast 2 o’clock,. fibroadenoma, favor lobular carcinoma in situ.. No family history.. S/P Retinal detachment operation 15 years. ago.. 24.2. |
352 | Case 24 | Courses of Treatment | HR(+) HER2(+) Breast Cancer | 24.1. . Courses of Treatment. Neoadjuvant chemotherapy (#6 cycles of. docetaxel and carboplatin and trastuzumab. and pertuzumab) + Operation + Post-. operative. radiation. ther. apy + Trastuzumab + Tamoxifen 20 mg/day.. 140. Pathology Report. Ductal Carcinoma In Situ. . 1. Post-chemotherapy status.. . 2. Size ... |
360 | Case 24 | Important Radiologic | HR(+) HER2(+) Breast Cancer | Important Radiologic. Findings. 134 135 136 137 138. 139. 24.3. |
366 | Case 24 | Patient History | HR(+) HER2(+) Breast Cancer | Patient History and Progress. Female/41 years old, pre-menopause.. Self-detected palpable mass lesion and nipple. discharge on right breast.. No family history.. S/P appendectomy, s/p hepatitis A.. 24.2. |
353 | Case 24 | Courses of Treatment | HR(+) HER2(-) Breast Cancer | 24.1. . Courses of Treatment. Neoadjuvant chemotherapy (#4 cycles of. doxorubicin & cyclophosphamide followed by. #4 cycles of docetaxel) & letrozole 2.5 mg/day. with leuprolide acetate + Operation + Post-. operative radiation therapy.. Operation (1st, Jan. 2021). Right breast conserving surgery, axillary lymph.... |
361 | Case 24 | Important Radiologic | HR(+) HER2(-) Breast Cancer | Important Radiologic. Findings. See Figs. 132, 133, 134, 135 and 136.. 24.3. |
367 | Case 24 | Patient History | HR(+) HER2(-) Breast Cancer | Patient History and Progress. Female/45 years old, pre-menopause.. Screen detected mass lesion on right breast 9. o’clock direction and right axillary LN.. No family history.. No comorbidities.. 24.2. |
354 | Case 24 | Courses of Treatment | HR(−) HER2(+) Breast Cancer | 24.1. . Courses of Treatment. Neoadjuvant chemotherapy (#3 cycles of. docetaxel and carboplatin and trastuzumab and. pertuzumab) + Operation + Post-operative radia. tion therapy + Trastuzumab and pertuzumab.. Operation. 176. . . HR(−) HER2(+) Breast Cancer. 526. Pathology Report. . 1. No residual tumor with stromal ... |
362 | Case 24 | Important Radiologic | HR(−) HER2(+) Breast Cancer | Important Radiologic. Findings. 168 169 170. 171. HR(−) HER2(+) Breast Cancer. 522. . . . Y. Kwon et al.. . After Neoadjuvant. Chemotherapy. 172 173 174 |
368 | Case 24 | Patient History | HR(−) HER2(+) Breast Cancer | Patient History and Progress. Female/55 years old, pre-menopause.. Self-detected palpable mass lesion on left. breast 10–12 o’clock direction.. No family history.. Hypertension.. 24.2. |
355 | Case 24 | Courses of Treatment | HR(−) HER2(−) Breast Cancer | 24.1. . Courses of Treatment. Neoadjuvant chemotherapy (#4 cycles of. doxorubicin and cyclophosphamide + #4. cycles of paclitaxel) + Operation + Post-. operative radiation therapy + Adjuvant. capecitabine.. Operation. 177. HR(−) HER2(−) Breast Cancer. 660. . . . . . E. S. Lee et al.. 661. . . . . . HR(−) ... |
363 | Case 24 | Important Radiologic | HR(−) HER2(−) Breast Cancer | Important Radiologic. Findings. 170 171. 172. After Neoadjuvant. Chemotherapy. 173 174 175. 176. 24.3. |
369 | Case 24 | Patient History | HR(−) HER2(−) Breast Cancer | Patient History and Progress. Female/44 years old, pre-menopause.. Self-detected mass lesion on right breast.. Family history of breast cancer, aunt. (paternal).. Family history of ovarian cancer, sister.. No comorbidities.. BRCA 1 and 2 mutation: Not detected,. EPCAM and MLH1 VUS (variant of uncertain).. 24.2. |
356 | Case 24 | Courses of Treatment | Local Recurrence | 24.1. . Courses of Treatment. Left breast IDC → Neoadjuvant chemotherapy. → Operation → Adjuvant therapy → Left chest. wall recurrence (IDC).. Primary Treatment. 160 161 162. 163. Neoadjuvant Chemotherapy. #4 cycles of doxorubicin and cyclophosphamide. followed by #4 cycles of docetaxel.. Operation. 164. Pathology Rep... |
370 | Case 24 | Patient History | Local Recurrence | Patient History and Progress. Female/45 years old, pre-menopause.. Screen detected mass lesion on upper outer. portion of left breast.. Outside result of biopsy: Invasive ductal. carcinoma.. Family history of breast cancer, maternal aunt,. another aunt.. No comorbidities.. BRCA 1 and 2 mutation: Not detected.. 24.2. |
357 | Case 24 | Courses of Treatment | Metastatic Breast Cancer | Courses of Treatment. Right breast cancer → Operation → Adjuvant. therapy → Lung metastasis.. Primary Treatment. Estrogen. receptor. Strong (7/7). 3. >2/3. Result. Intensity. Positive %. Progesterone. receptor. Strong (7/7). 3. >2/3. C-erbB2. Negative (1+). Ki-67. Positive in. 30% of tumor. cells. Adjuvant Therapy. Adj... |
371 | Case 24 | Patient History | Metastatic Breast Cancer | 24.2. |
372 | Case 25 | Courses of Treatment | Benign and Proliferative | 25.1. . Courses of Treatment. →2021-07-27 excision, Lt.. Diagnosis. • Breast, left, excision:. –. – Atypical ductal hyperplasia involving. intraductal papilloma.. –. – Tubular adenoma.. 26. |
380 | Case 25 | Important Radiologic | Benign and Proliferative | Important Radiologic. Findings. 49. 50. Benign and Proliferative Case Series. 48. . . 25.3. |
386 | Case 25 | Patient History | Benign and Proliferative | Patient History and Progress. Female/46 years old, pre-menopause.. Screen detected mass lesion on left breast 3. o’clock direction.. Outside result of biopsy: Intraductal papilloma.. No family history.. No comorbidities.. 25.2. |
373 | Case 25 | Courses of Treatment | Carcinoma In Situ | 25.1. . Courses of Treatment. Operation + Postoperative radiation therapy. (Left) + Tamoxifen 20 mg/day for 5 years.. Operation. 116. 117. Pathology Report. Right.. Lobular carcinoma in situ. . 1. Size of tumor: 0.3 cm.. . 2. Nuclear grade: low.. . 3. Necrosis: absent.. . 4. Architectural pattern: solid.. . 5. Sk... |
381 | Case 25 | Important Radiologic | Carcinoma In Situ | Important Radiologic. Findings. 114. 115. 25.3. |
387 | Case 25 | Patient History | Carcinoma In Situ | Patient History and Progress. Female/52 years old, pre-menopause.. Screen detected mass lesion on left breast. 1 o’clock direction.. Outside result of biopsy: Left breast 1 o’clock,. ductal carcinoma in situ, r/o invasion.. No family history.. S/P Robotic cholecystectomy (GB stone).. BRCA 1 and 2: Not examination.. 25.... |
374 | Case 25 | Courses of Treatment | HR(+) HER2(+) Breast Cancer | 25.1. . Courses of Treatment. Operation + Adjuvant chemotherapy (#4. cycles of doxorubicin and cyclophosphamide. followed by #4 cycles of docetaxel and. . trastuzumab) + Post-operative radiation ther. apy + Trastuzumab + Letrozole 2.5 mg/day.. . 145. 146. Pathology Report. [Right].. . 1. Invasive Ductal Carcinom... |
382 | Case 25 | Important Radiologic | HR(+) HER2(+) Breast Cancer | Important Radiologic. Findings. 141 142 143. 144. 25.3. |
388 | Case 25 | Patient History | HR(+) HER2(+) Breast Cancer | Patient History and Progress. Female/62 years old, post-menopause.. Screen detected mass lesion on right breast 5. o’clock direction and left breast subareolar area.. No family history.. Hypertension, dyslipidemia.. 25.2. |
375 | Case 25 | Courses of Treatment | HR(+) HER2(-) Breast Cancer | Courses of Treatment. Neoadjuvant therapy (giredestrant 30 mg/day. with palbociclib 100 mg/day) + Operation +. Adjuvant chemotherapy (#4 cycles of doxorubi. cin & cyclophosphamide followed by #4 cycles of. docetaxel) + Post-. operative radiation ther. apy + Letrozole 2.5 mg/day.. Operation. Left breast conserving ... |
383 | Case 25 | Important Radiologic | HR(+) HER2(-) Breast Cancer | Important Radiologic. Findings. See Figs. 139, 140, 141, 142 and 143.. 25.3. |
389 | Case 25 | Patient History | HR(+) HER2(-) Breast Cancer | o’clock direction and left axillary LN.. No family history.. No comorbidities.. 25.2. |
376 | Case 25 | Courses of Treatment | HR(−) HER2(+) Breast Cancer | 25.1. . Courses of Treatment. Operation + Post-operative radiation therapy. (adjuvant chemotherapy refuse).. Operation. 180. Pathology Report. Invasive Ductal Carcinoma. 1. Size of invasive component: 2.5 cm (pT2).. 2. Size of intraductal component: 4.0 cm.. 3. Histologic grade: 3/3 (tubule formation: 3/3,. nucle... |
384 | Case 25 | Important Radiologic | HR(−) HER2(+) Breast Cancer | Important Radiologic Findings. 177 178. 179. . Y. Kwon et al.. 527. . . . 25.3. |
390 | Case 25 | Patient History | HR(−) HER2(+) Breast Cancer | Patient History and Progress. Female/82 years old, post-menopause.. Screen detected mass lesion on left breast 2:30. o’clock direction.. No family history.. S/P Left hemiplegia (due to brain hemor. rhage), hypertension, S/P spinal stenosis opera. tion, s/p Tuberculosis.. 25.2. |
377 | Case 25 | Courses of Treatment | HR(−) HER2(−) Breast Cancer | 25.1. . Courses of Treatment. Neoadjuvant chemotherapy (#4 cycles of doxo. rubicin and cyclophosphamide + #4 cycles of. docetaxel) + Operation + Post-operative radia. tion therapy + Adjuvant capecitabine.. Operation. 185. Pathology Report. Invasive Ductal Carcinoma with (a) focal squa. mous differentiation, (b) foc... |
385 | Case 25 | Important Radiologic | HR(−) HER2(−) Breast Cancer | Important Radiologic. Findings. 178 179. 180. 25.3. . After Neoadjuvant. Chemotherapy. 181 182 183. 184. 25.4. |
391 | Case 25 | Patient History | HR(−) HER2(−) Breast Cancer | Patient History and Progress. Female/70 years old, post-menopause.. Screen detected mass lesion on left breast 2. o’clock direction.. Family history of breast cancer, cousin. (paternal).. Macular degeneration.. BRCA 1 and 2 mutation: Not tested.. 25.2. |
378 | Case 25 | Courses of Treatment | Local Recurrence | 25.1. . Courses of Treatment. Left breast IDC → Operation → Adjuvant ther. apy → Left breast recurrence (DCIS).. Primary Treatment. Operation. Nov. 2007 Left breast conserving surgery, axil. lary lymph node dissection (outside).. Pathology Report. Invasive Ductal Carcinoma. . 1. Size of tumor: 1.1 cm (pT1c).. . 2. ... |
392 | Case 25 | Patient History | Local Recurrence | Patient History and Progress. Female/69 years old, post-menopause.. For chemotherapy after left breast cancer. surgery.. No family history.. s/p Left breast conserving surgery, s/p total. Thyroidectomy (thyroid cancer).. s/p. Hysterectomy. and. bilateral. salpingo-oophorectomy.. 25.2. |
379 | Case 25 | Courses of Treatment | Metastatic Breast Cancer | Courses of Treatment. Left breast cancer → Operation → Adjuvant. therapy → Ipsilateral breast skin metastasis.. Estrogen. receptor. Strong (8/8). 3. >2/3. Progesterone. receptor. Strong (8/8). 3. >2/3. C-erbB2. Negative (0). Ki-67. Positive in. 7% of tumor. cells. Adjuvant Therapy. Tamoxifen 20 mg/day for 0.75 year.. T... |
393 | Case 25 | Patient History | Metastatic Breast Cancer | Hyperthyroidism,. s/p. bilateral. salpingo-oophorectomy.. 25.2. |
394 | Case 26 | Courses of Treatment | Benign and Proliferative | 26.1. . Courses of Treatment. →2021-06-16 excision, Rt.. Pathology Report. Diagnosis. • Breast, right, excision:. –. – Intraductal papilloma with usual ductal. hyperplasia.. . . Benign and Proliferative Case Series. 50. 27. |
402 | Case 26 | Important Radiologic | Benign and Proliferative | Important Radiologic. Findings. 51. 52. 26.3. |
408 | Case 26 | Patient History | Benign and Proliferative | Patient History and Progress. Female/72 years old, post-menopause.. Screen detected nodular asymmetry on outer. central portion of right breast.. No family history.. s/p Total thyroidectomy (thyroid cancer).. C. W. Lee et al.. 49. 26.2. |
395 | Case 26 | Courses of Treatment | Carcinoma In Situ | 26.1. . Courses of Treatment. Operation + Tamoxifen 20 mg/day for 5 years.. Operation. 121. 122. Pathology Report. Lobular carcinoma in situ, pathological TN. category (AJCC 2017): pTis. . 1. Size of tumor: up to 0.6 cm (pTis).. . 2. Nuclear grade: low.. . . . Carcinoma In Situ. 110. . 3. Necrosis: absent.. . 4. ... |
403 | Case 26 | Important Radiologic | Carcinoma In Situ | Important Radiologic. Findings. 118 119. 120. 26.3. |
409 | Case 26 | Patient History | Carcinoma In Situ | Patient History and Progress. Female/48 years old, pre-menopause.. Screen detected mass and microcalcification. on upper portion of right breast.. No family history.. No comorbidities.. 26.2. |
396 | Case 26 | Courses of Treatment | HR(+) HER2(+) Breast Cancer | 26.1. . Courses of Treatment. Neoadjuvant chemotherapy (#6 cycles of. docetaxel and carboplatin and trastuzumab. and pertuzumab) + Operation + Post-. operative radiation therapy + Trastuzumab +. Letrozole 2.5 mg/day.. 153. 154. Pathology Report. Invasive Ductal Carcinoma. 1. Post-chemotherapy status.. 2. Size o... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.